BACKGROUND: The incidence and risk factors for atrial arrhythmia (AA; atrial fibrillation and atrial flutter) in adults with systemic right ventricle (sRV), specifically congenitally corrected transposition of the great arteries and dextro-transposition of the great arteries palliated with atrial switch procedures, are not well understood. This study aims to better define these risks. METHODS: Adults with sRV presenting to Mayo Clinic between 2000 and 2022 were identified. Their clinical characteristics, electrocardiographic, and echocardiographic parameters at the time of first presentation were recorded. The incidence of sustained AA (>30 seconds) during follow-up was documented. Cox regression analysis was used to identify associations of incident atrial fibrillation/atrial flutter and mortality during follow-up. RESULTS: Among 447 patients with sRV (median age, 33.1 [24.6–42.8], 55.9% male, 247 cm 3 -TGA; 200 dextro-transposition of the great arteries postatrial switch), AA was present at first visit in 113 (25.3%). Out of the remaining 334 patients, new-onset AA occurred in 125 (37.4%) patients during a median follow-up of 11.1 years (interquartile range, 3.6–19.3). Isolated atrial fibrillation was observed in 89 (37.4%), isolated atrial flutter in 76 (31.9%), and both atrial fibrillation and atrial flutter in 73 (30.7%) patients. In multivariable analysis, the risk factors for incident AA included age (hazard ratio, 1.04 [1.03–1.06]; P <0.001), d-TGA (hazard ratio, 1.96 [1.00–3.85]; P =0.05), and QRS duration (hazard ratio, 1.01 [1.00–1.02]; P =0.02). AA was associated with hospitalization for heart failure in 19% of patients. Among those treated with anti-arrhythmic drugs and ablation, recurrence occurred in over 50% of patients. AA was not an independent predictor of mortality. CONCLUSIONS: AA occurred in more than half of this cohort with sRV, with risk increasing significantly after the third decade of life. Advancing age, dextro-transposition of the great arteries, and prolonged QRS duration were associated with increased risk of AA. Close monitoring for AA and early interventions are warranted in all adults with sRV.